Evotec SE (ETR:EVT – Get Free Report) shares were up 0.9% on Thursday . The stock traded as high as €8.10 ($8.53) and last traded at €8.00 ($8.42). Approximately 382,704 shares traded hands during trading, a decline of 72% from the average daily volume of 1,360,000 shares. The stock had previously closed at €7.93 ($8.35).
Evotec Price Performance
The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83. The stock has a 50 day simple moving average of €8.64 and a two-hundred day simple moving average of €7.55. The firm has a market cap of $1.45 billion, a PE ratio of -8.51, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
- Five stocks we like better than Evotec
- Bank Stocks – Best Bank Stocks to Invest In
- Bloom Energy: Powering the Future With Decentralized Energy
- The Most Important Warren Buffett Stock for Investors: His Own
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
